Indaptus Therapeutics, Inc. (INDP) — Institutional Holders, Q2 2026
9 institutional investment managers reported a INDP position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.2M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
INDP in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- HRT FINANCIALNew · +206,077 sh+$618.2K
- JANE STREET GROUPNew · +53,811 sh+$161.4K
- VANGUARD CAPITAL MANAGEMENTNew · +33,652 sh+$101.0K
- GEODE CAPITAL MANAGEMENTAdded · +29,463 sh+$88.4K
- VANGUARD FIDUCIARYNew · +13,967 sh+$41.9K
Biggest sellers
- CITADEL ADVISORSSold out · -39,018 sh-$117.1K
- Tower Research Capital (TRC)Sold out · -1,890 sh-$5.7K
INDP 13F holders ranked 1–9 of 9
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | HRT FINANCIAL#1 · 206,077 sh | 206,077 | $618.0K | <0.01% | New |
| 2 | GEODE CAPITAL MANAGEMENT#2 · 56,470 sh | 56,470 | $169.4K | 0.00% | +109.1% |
| 3 | JANE STREET GROUP#3 · 53,811 sh | 53,811 | $161.4K | 0.00% | New |
| 4 | VANGUARD CAPITAL MANAGEMENT#4 · 33,652 sh | 33,652 | $101.0K | 0.00% | New |
| 5 | VANGUARD FIDUCIARY#5 · 13,967 sh | 13,967 | $41.9K | 0.00% | New |
| 6 | MILLENNIUM MANAGEMENT#6 · 11,586 sh | 11,586 | $34.8K | 0.00% | New |
| 7 | MORGAN STANLEY#7 · 8,936 sh | 8,936 | $26.8K | 0.00% | +231.3% |
| 8 | UBS Group AG#8 · 478 sh | 478 | $1.4K | 0.00% | New |
| 9 | SBI Securities , Ltd.#9 · 17 sh | 17 | $51.00 | — | 0.0% |
Funds that sold out of INDP in Q2 2026 (2)
Held INDP at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| CITADEL ADVISORS39,018 sh | 39,018 | $71.0K |
| Tower Research Capital (TRC)1,890 sh | 1,890 | $3.4K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.